Dave Caspers - 01 Apr 2025 Form 4 Insider Report for Ardent Health Partners, Inc. (ARDT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Apr 2025, 17:31:49 UTC
Prior SEC filing
02 Apr 2025
Next SEC filing
02 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen C. Petrovich, Attorney-in-Fact

Key filing fact

Dave Caspers filed Form 4 for Ardent Health Partners, Inc. (ARDT) on 02 Apr 2025.

Key facts

  • This page summarizes Dave Caspers's Form 4 filing for Ardent Health Partners, Inc. (ARDT).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Apr 2025, 17:31.

Change

  • Previous filing in this sequence was filed on 02 Apr 2025.
  • Current net transaction value: -$32,166.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARDT transaction

Common Stock

Award

Transaction value
$0
Shares
+7,711
Change %
Price
$0.000000
Shares after
7,711
Date
01 Apr 2025
Ownership
Direct
Footnotes
F1
ARDT transaction

Common Stock

Tax liability

Transaction value
$32,166
Shares
-2,480
Change %
-32%
Price
$12.97
Shares after
5,231
Date
01 Apr 2025
Ownership
Direct
Footnotes
F2, F3
ARDT transaction

Common Stock

Award

Transaction value
$0
Shares
+33,057
Change %
+632%
Price
$0.000000
Shares after
38,288
Date
01 Apr 2025
Ownership
Direct
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents shares of the Issuer's common stock awarded as part of a signing bonus upon commencement of employment with the Issuer.

Footnote F2

Shares withheld for payment of taxes payable upon stock award.

Footnote F3

Represents the closing price of the common stock of the Issuer on April 1, 2025.

Footnote F4

Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2025, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .